- Home
- PCB vs AVIR Comparison
PCB vs AVIR Comparison
Compare PCB & AVIR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PCB
- AVIR
- Stock Information
- Founded
- PCB 2003
- AVIR 2012
- Country
- PCB United States
- AVIR United States
- Employees
- PCB N/A
- AVIR N/A
- Industry
- PCB Major Banks
- AVIR Medicinal Chemicals and Botanical Products
- Sector
- PCB Finance
- AVIR Health Care
- Exchange
- PCB Nasdaq
- AVIR Nasdaq
- Market Cap
- PCB 289.7M
- AVIR 277.8M
- IPO Year
- PCB N/A
- AVIR 2020
- Fundamental
- Price
- PCB $22.39
- AVIR $3.66
- Analyst Decision
- PCB Hold
- AVIR Hold
- Analyst Count
- PCB 2
- AVIR 1
- Target Price
- PCB $22.25
- AVIR $6.00
- AVG Volume (30 Days)
- PCB 28.8K
- AVIR 327.9K
- Earning Date
- PCB 07-24-2025
- AVIR 08-07-2025
- Dividend Yield
- PCB 3.73%
- AVIR N/A
- EPS Growth
- PCB 29.75
- AVIR N/A
- EPS
- PCB 2.14
- AVIR N/A
- Revenue
- PCB $102,259,000.00
- AVIR N/A
- Revenue This Year
- PCB $21.62
- AVIR N/A
- Revenue Next Year
- PCB $9.17
- AVIR N/A
- P/E Ratio
- PCB $10.01
- AVIR N/A
- Revenue Growth
- PCB 9.08
- AVIR N/A
- 52 Week Low
- PCB $16.00
- AVIR $2.46
- 52 Week High
- PCB $22.45
- AVIR $4.15
- Technical
- Relative Strength Index (RSI)
- PCB 62.98
- AVIR 58.86
- Support Level
- PCB $21.39
- AVIR $3.45
- Resistance Level
- PCB $21.88
- AVIR $3.60
- Average True Range (ATR)
- PCB 0.41
- AVIR 0.13
- MACD
- PCB 0.08
- AVIR 0.00
- Stochastic Oscillator
- PCB 96.97
- AVIR 62.26
About PCB PCB Bancorp
PCB Bancorp is a bank holding company, which engages in the provision of consumer and commercial banking services. It provides Personal, Business, and Loan services, which provide banking, lending, and digital, tools, home loans, and others. Also, it offers a broad range of loans, deposits, and other products and services predominantly to small and middle-market businesses and individuals. The company provided it's services in Los Angeles and Orange Counties, California; Bellevue, Washington; and Atlanta, Georgia.
About AVIR Atea Pharmaceuticals Inc.
Atea Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on discovering, developing, and commercializing antiviral therapeutics to improve the lives of patients suffering from serious viral infections. The company is developing its product candidate, bemnifosbuvir, for the treatment of COVID-19, the disease caused by infection with Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and its variants and also developing bemnifosbuvir in combination with ruzasvir for the treatment of Hepatitis C (HCV).